Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease

Rheumatology International

Volumn 36, Issue 1, 2016, Pages 125-131

  Go, Dong Jin ^a,b   Park, Jin Kyun ^a,b   Kang, Eun Ha ^c   Kwon, Hyun Mi ^a   Lee, Yun Jong ^c   Song, Yeong Wook ^a,b   Lee, Eun Bong ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Amyopathic dermatomyositis; Cyclosporine; Dermatomyositis; Interstitial lung disease; Survival

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HAND TREMOR; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFECTION; INTERSTITIAL LUNG DISEASE; LEUKOPENIA; LUNG FUNCTION; MALE; MIDDLE AGED; MORTALITY; NEPHROTOXICITY; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SURVIVAL; THERAPY DELAY; THORAX PAIN; TIME TO TREATMENT; TREATMENT OUTCOME; TUBERCULOSIS; UPPER ABDOMINAL PAIN; COMBINATION DRUG THERAPY; COMPLICATION; DRUG ADMINISTRATION; LUNG DISEASES, INTERSTITIAL; PROGNOSIS; SURVIVAL RATE; TIME FACTOR;

ADULT; CYCLOSPORINE; DERMATOMYOSITIS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84953835104     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-015-3328-8     Document Type: Article

References (29)

1. Marie I, Hatron P, Dominique S, Cherin P, Mouthon L, Menard JF (2011) Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 63:3439–3447
2. Fathi M, Vikgren J, Boijsen M, Tylen U, Jorfeldt L, Tornling G et al (2008) Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 59:677–685
3. Chen I-J, Wu Y-JJ, Lin C-W, Fan K-W, Luo S-F, Ho H-H et al (2009) Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 28:639–646
4. Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M, Cadranel J, Delaval P, Ternamian P et al (2003) Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 22:245–250
5. Vij R, Strek ME (2013) Diagnosis and treatment of connective tissue disease-associated interstitial lung disease connective tissue-interstitial lung disease. Chest 143:814–824
6. Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626–636
7. Suda T, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Naito T et al (2006) Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 28:1005–1012
8. Kang E, Lee E, Shin K, Im C, Chung D, Han S et al (2005) Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology 44:1282–1286
9. Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF et al (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47:614–622
10. Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M et al (1999) Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine treatment with cyclosporine. J Rheumatol 26:1527–1533
11. Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M et al (2005) Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol 32:58–64
12. Takada K, Kishi J, Miyasaka N (2007) Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis/polymyositis: a retrospective study. Mod Rheumatol 17:123–130
13. Kotani T, Makino S, Takeuchi T, Kagitani M, Shoda T, Hata A et al (2008) Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis. J Rheumatol 35:254–259
14. Takada K, Nagasaka K, Miyasaka N (2005) Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity 38:383–392
15. Maeda K, Kimura R, Komuta K, Igarashi T (1997) Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Rheumatol 26:24–29
16. Labirua-Iturburu A, Selva-O’Callaghan A, Martinez-Gomez X, Trallero-Araguás E, Labrador-Horrillo M, Vilardell-Tarrés M (2012) Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. Clin Exp Rheumatol 31:436–439
17. Bohan A, Peter JB, Bowman RL, Pearson CM (1977) A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56:255–286
18. Mino M, Noma S, Taguchi Y, Tomii K, Kohri Y, Oida K (1997) Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol 169:83–87
19. Arakawa H, Yamada H, Kurihara Y, Nakajima Y, Takeda A, Fukushima Y et al (2003) Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositisserial high-resolution CT findings and functional correlation. Chest 123:1096–1103
20. Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, Spizarny DL et al (1997) Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 169:977–983
21. Kurasawa K, Nawata Y, Takabayashi K, Kumano K, Kita Y, Takiguchi Y et al (2002) Activation of pulmonary T cells in corticosteroid-resistant and-sensitive interstitial pneumonitis in dermatomyositis/polymyositis. Clin Exp Immunol 129:541–548
22. Yamadori I, Fujita J, Kajitani H, Bandoh S, Tokuda M, Ohtsuki Y et al (2001) Lymphocyte subsets in lung tissues of interstitial pneumonia associated with untreated polymyositis/dermatomyositis. Rheumatol Int 21:89–93
23. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies what progress has been made in the past 35 years? Chest 138:1464–1474
24. Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M et al (2005) Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 32:1719–1726
25. Kotani T, Takeuchi T, Makino S, Hata K, Yoshida S, Nagai K et al (2011) Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia. Clin Rheumatol 30:1021–1028
26. Nagasaka K, Harigai M, Tateishi M, Hara M, Yoshizawa Y, Koike T et al (2003) Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis. Mod Rheumatol 13:231–238
27. Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard J-F et al (2012) Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum 41:890–899
28. Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T et al (2011) Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 147:391–398
29. Mimori T, Nakashima R, Hosono Y (2012) Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment. Curr Rheumatol Rep 14:264–274